Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) ELISA试剂盒

PCSK9 encodes a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family. 再加上,我们可以发PCSK9 抗体 (160)PCSK9 蛋白 (64)和数多这个蛋白质的别的产品。

list all ELISA KIts 基因 基因ID UniProt
PCSK9 255738 Q8NBP7
PCSK9 100102 Q80W65
PCSK9 298296 P59996

antibodies-online.cn销售最多的PCSK9 ELISA试剂盒

Showing 10 out of 74 products:

产品编号 适用 灵敏度 范围 图像 规格 供应商 交付 价格 详细
0.11 ng/mL 0.45-30 ng/mL Typical standard curve 96 Tests Log in to see 9至12个工作日
¥3,994.38
详细
小鼠 10pg/mL 62.5-4000 pg/mL Mouse PCSK9 PicoKine ELISA Kit standard curve 96 Tests Log in to see 26至32个工作日
¥4,348.49
详细
1.1 pg/mL 1.1-800 pg/mL Typical standard curve 96 Tests Log in to see 9至12个工作日
¥4,654.26
详细
大鼠 1.25 ng/mL 3.125-200 ng/mL 96 Tests Log in to see 9至11个工作日
¥4,527.90
详细
0.12 ng/mL 0.312-20 ng/mL   96 Tests Log in to see 24至29个工作日
¥4,987.13
详细
大鼠 0.156-10 ng/mL   96 Tests Log in to see 24至29个工作日
¥5,179.31
详细
豚鼠 0.094 ng/mL 0.156-10 ng/mL   96 Tests Log in to see 6至8个工作日
¥5,717.40
详细
Pig 0.469 ng/mL 0.781-50 ng/mL   96 Tests Log in to see 6至8个工作日
¥5,717.40
详细
0.188 ng/mL 0.313-20 ng/mL   96 Tests Log in to see 6至8个工作日
¥5,717.40
详细
小鸡 4.688 ng/mL 7.813-500 ng/mL   96 Tests Log in to see 6至8个工作日
¥5,717.40
详细

引用最多的PCSK9 ELISA试剂盒

  1. Human PCSK9 ELISA Kit for Sandwich ELISA - ABIN820112 : Dogan, Akman, Simsek, Ozdem, Comak, Gokceoglu, Kardelen, Koyun: Assessment of left ventricular function by tissue Doppler echocardiography in pediatric chronic kidney disease. in Renal failure 2015 (PubMed)
    Show all 2 references for 820112

  2. Mouse (Murine) PCSK9 ELISA Kit for Sandwich ELISA - ABIN1889344 : Seidah, Benjannet, Wickham, Marcinkiewicz, Jasmin, Stifani, Basak, Prat, Chretien: The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. in Proceedings of the National Academy of Sciences of the United States of America 2003 (PubMed)

适于 PCSK9 相互作用对的更多 ELISA 试剂盒

Human Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) interaction partners

  1. PCSK9 inhibits lipoprotein(a) clearance through the LDLR (显示 LDLR ELISA试剂盒).

  2. PCSK9 variants reduced fasting LDL-C as well as fasting triglycerides.

  3. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR (显示 LDLR ELISA试剂盒) mutations modifies the phenotype of familial hypercholesterolemia

  4. PCSK9 associated with Familial Hypercholesterolemia and Polygenic Hypercholesterolemia in patients with Acute Coronary Syndrome , age /=160 mg/dl.

  5. Results clearly that PCSK9 serum concentrations were associated to liver function and mortality, pointed to the disturbance of steroid regulation in patients with end-stage liver disease and an association of such disturbance with mortality. Further studies are required to acquire a more detailed understanding of the role of PCSK9 in liver-related mortality.

  6. Use Crispr-Cas (显示 CSE1L ELISA试剂盒) system to introduce nonsense variants into PCSK9 to lower blood cholesterol levels.

  7. PCSK9 decreased in youth participating in an intensive dietary intervention. Change in HOMA-IR was associated with change in PCSK9, independent of weight loss, suggesting an important relationship with insulin (显示 INS ELISA试剂盒) sensitivity.

  8. these studies support that reductions in Lp(a (显示 APOA ELISA试剂盒)) with PCSK9 inhibition are partly due to increased LDLR (显示 LDLR ELISA试剂盒)-mediated uptake. In most situations, Lp(a (显示 APOA ELISA试剂盒)) appears to compete poorly with LDL for LDLR (显示 LDLR ELISA试剂盒) binding and internalization, but when LDLR (显示 LDLR ELISA试剂盒) expression is increased with evolocumab, particularly in the setting of low circulating LDL, Lp(a (显示 APOA ELISA试剂盒)) is reduced.

  9. Plasma levels of proprotein convertase subtilisin/kexin type 9 (PCSK9), apolipoprotein C-III (apoC3 (显示 APOC3 ELISA试剂盒)) and small dense low density lipoprotein cholesterol (sdLDL-C) showed significant interactions with current dyslipidemias, and were predictive in the screening.

  10. Some loss of function variants in PCSK9 are associated with enhanced LDL cholesterol lowering response to statin therapy.

Mouse (Murine) Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) interaction partners

  1. PCSK9 inhibits lipoprotein(a) clearance through the LDLR (显示 LDLR ELISA试剂盒).

  2. Use Crispr-Cas (显示 CTNND1 ELISA试剂盒) system to introduce nonsense variants into PCSK9 to lower blood cholesterol levels.

  3. Studied the combination model of a single AAV-PCSK9 injection, high-fat diet, and partial carotid ligation which induces robust atherosclerosis in the flow-disturbed carotid artery within 3 weeks in C57 mice, and results suggest this is a quick and convenient model to study atherosclerosis and mechanisms using any knockout or transgenic mice without having to generate double knockouts.

  4. These observations suggest positive feedback interplay between SMC (显示 DYM ELISA试剂盒)-derived PCSK9 and mtDNA damage in the proinflammatory milieu involving mtROS. This interaction results in cellular injury, characterized by apoptosis-a hallmark of atherosclerosis.

  5. AdipoR activation by agonists regulated PCSK9 expression and inhibits atherosclerosis in apoE (显示 APOE ELISA试剂盒)(-/-) mice.

  6. Adeno (显示 ADORA2A ELISA试剂盒)-associated virus mediated infection with a mouse PCSK9 gain-of-function mutation is a rapid, easy, and efficient approach for inducing hypercholesterolemia and promoting abdominal aortic aneurysms in C57BL/6 mice infused with angiotensin II.

  7. conditions that cause ER stress regardless of their ability to dysregulate ER Ca(2 (显示 CA2 ELISA试剂盒)+) inhibit PCSK9 secretion, thereby reducing PCSK9-mediated LDLR (显示 LDLR ELISA试剂盒) degradation and promoting LDLR (显示 LDLR ELISA试剂盒)-dependent hepatic cholesterol uptake.

  8. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor (显示 LDLR ELISA试剂盒) Degradation.

  9. PCSK9 increases hepatic lipid and lipoprotein production via apoE (显示 APOE ELISA试剂盒)- and LDLR (显示 LDLR ELISA试剂盒)-dependent mechanisms

  10. Podocyte damage triggers marked inductions in plasma PCSK9, and knockout of Pcsk9 ameliorates dyslipidemia in a mouse model of nephrotic syndrome.

PCSK9 抗原简介

Antigen Summary

This gene encodes a proprotein convertase belonging to the proteinase K subfamily of the secretory subtilase family. The encoded protein is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the endoplasmic reticulum. The protein may function as a proprotein convertase. This protein plays a role in cholesterol homeostasis and may have a role in the differentiation of cortical neurons. Mutations in this gene have been associated with a third form of autosomal dominant familial hypercholesterolemia (HCHOLA3).

Gene names and symbols associated with PCSK9

  • proprotein convertase subtilisin/kexin type 9 (pcsk9) 抗体
  • proprotein convertase subtilisin/kexin type 9 (PCSK9) 抗体
  • proprotein convertase subtilisin/kexin type 9 (Pcsk9) 抗体
  • proprotein convertase subtilisin/kexin type 9-like (LOC100620501) 抗体
  • AI415265 抗体
  • AI747682 抗体
  • FH3 抗体
  • HCHOLA3 抗体
  • LDLCQ1 抗体
  • NARC-1 抗体
  • Narc1 抗体
  • PC9 抗体

Protein level used designations for PCSK9

proprotein convertase subtilisin/kexin type 9 , convertase subtilisin/kexin type 9 preproprotein , neural apoptosis regulated convertase 1 , subtilisin/kexin-like protease PC9 , NARC-1 , convertase subtilisin , neural apoptosis-regulated convertase 1 , proprotein convertase 9 , proprotein convertase PC9 , proprotein convertase subtilisin/kexin type 9 preproprotein , Proprotein convertase 9 , Subtilisin/kexin-like protease PC9

GENE ID SPECIES
495509 Xenopus laevis
100150316 Danio rerio
100544916 Meleagris gallopavo
255738 Homo sapiens
100102 Mus musculus
298296 Rattus norvegicus
424664 Gallus gallus
100731533 Cavia porcellus
717147 Macaca mulatta
100971792 Pan paniscus
456880 Pan troglodytes
100395116 Callithrix jacchus
100620501 Sus scrofa
PCSK9 (PCSK9) ELISA试剂盒 精选生产商
您还需要查找其他产品吗?